Immunotherapy: Open Access
Open Access

Hiss Vaccine for treatment of cancer in early stages

2^nd International Conference on Tumor & Cancer Immunology and Immunotherapy

July 17-18, 2017 Chicago, USA

Hussein A Mohamed Ramadan

BSU University, Egypt

Scientific Tracks Abstracts: Immunotherapy (Los Angel)

Abstract :

This work is a mutation in the medical field capable of changing our vision in cytology and malignancy of cancer. Our immune systems is so sensitive to the extent that make cancer understand the nature of our body more than we do our immune system deal with cancer cell as any other cell. Moreover, the more the cancer cell is increased and spread the more the intimate relation with the immune system. This consequently results in triggering cancer growth as well suppressing the immune system. At this moment cancer is capable of metastasis without any resistance from the immune system in asymptomatic manner in its early stage. Unfortunately this is coupled with secretion of certain hormone at certain areas that is linked with dissipation of calcium. This idea will deal with cancer through the use of vaccine that will turn cancer from being malignant into disorder that have symptoms in its early stage exactly flu like scenario. This will turn cancer to be easy identified and give a chance for simple affordable and available treatment at drug store.

Biography :

Hussein A Mohamed Ramadan, an Physical Therapy Student BSc from BSU University, Egypt.

Email: dr.hussien4444@gmail.com